Trent, died days before Christmas after her flight to the Dominican Republic was forced to divert to Puerto Rico ...

New food hygiene ratings have been awarded to 15 of Cheshire East’s establishments, the Food Standards Agency’s website shows ...

Teacher Catherine Mills was left with lifechanging injuries after the teenage driver failed to see her when she pulled out at ...

Teacher and A Level examiner Catherine Mills, 53, suffered multiple injuries after 19-year old motorist Leah MacKinnon pulled ...

AstraZeneca adjusts its U.S. strategy by proposing drug price cuts and expanding local production in response to pressure from President Trump. The company aims to balance pricing globally while ...

AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market.

AstraZeneca Plc may sell some of its medicines directly to patients in the US, joining several other drugmakers that have plans to bypass middlemen or are considering them.

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly transferring manufacturing” across the Atlantic.

Total revenue rose 11 per cent to $28bn (£12.98bn) in the first half of the year, driven by double-digit growth in Oncology and BioPharmaceuticals, the pharmaceutical giant told markets this morning ...